Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma

• Status: Unknown status
• Trial end date: 2020-08-31
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to explore the effect of SAMe on recurrence after radical treatment of Primary liver cancer.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beijing Insight Science & Technology Co. Ltd.

Criteria

Inclusion Criteria:

• Patient must sign the informed consent prior to the beginning of any study-related procedures;

• Patients diagnosed of Primary liver cancer;

• BCLC Stage：Stage 0、Stage A;

• Accept radical treatment;

Exclusion Criteria:

• With any other anti-cancer treatment before or after the surgery;

• Patients with extrahepatic metastasis;

• Patients with apparent cardiac, pulmonary, cerebral and renal dysfunction;

• Subjects accepting other trial drugs or participating in other clinical trials;

• Female with pregnancy or during the lactation period.